Literature DB >> 26982786

Phaeohyphomycosis in renal transplantation: report of two cases.

Walmar Roncalli Pereira de Oliveira1, Maria Fernanda Longo Borsato1, Maria Luiza Ducati Dabronzo1, Cyro Festa Neto1, Larissa Aragão Rocha1, Ricardo Spina Nunes1.   

Abstract

Phaeohyphomycosis is an infection caused by a filamentous fungus that contains pigment melanin in its cell wall. We report two cases caused by Exophiala sp. emphasizing the clinical variability of the disease, as well as diagnostic and therapeutic difficulties of this opportunistic infection in immunosuppressed patients (kidney transplant).

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26982786      PMCID: PMC4782654          DOI: 10.1590/abd1806-4841.20163954

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  10 in total

1.  Subcutaneous phaeohyphomycosis due to Alternaria infectoria in a renal transplant patient: surgical treatment with no long-term relapse.

Authors:  Rafael Salido-Vallejo; María José Linares-Sicilia; Gloria Garnacho-Saucedo; Marina Sánchez-Frías; Francisco Solís-Cuesta; Josepa Gené; José Carlos Moreno-Giménez
Journal:  Rev Iberoam Micol       Date:  2012-07-05       Impact factor: 1.044

2.  Subcutaneous phaeohyphomycosis in a renal transplant recipient successfully treated with voriconazole.

Authors:  Christian Grønhøj Larsen; Maiken Cavling Arendrup; Elizabeth Krarup; Michael Pedersen; Søren Thybo; Frederik Grønhøj Larsen
Journal:  Acta Derm Venereol       Date:  2009-11       Impact factor: 4.437

3.  Phaeohyphomycosis caused by Pyrenochaeta romeroi mimicking a plantar wart in a kidney transplant recipient.

Authors:  M A Ocampo; J Kanitakis; A-L Bienvenu; C Chauvet; S Euvrard
Journal:  Transpl Infect Dis       Date:  2012-11-02       Impact factor: 2.228

4.  Phaeohyphomycosis in kidney transplant patients.

Authors:  A Mesa; J Henao; M Gil; G Durango
Journal:  Clin Transplant       Date:  1999-06       Impact factor: 2.863

5.  Subcutaneous phaeohyphomycosis (mycotic cyst).

Authors:  Rafael Isa-Isa; Carlos García; Mariel Isa; Roberto Arenas
Journal:  Clin Dermatol       Date:  2012 Jul-Aug       Impact factor: 3.541

Review 6.  Cutaneous phaeohyphomycosis in renal allograft recipients: report of 2 cases and review of the literature.

Authors:  Sylvie E M Vermeire; Hylke de Jonge; Katrien Lagrou; Dirk R J Kuypers
Journal:  Diagn Microbiol Infect Dis       Date:  2010-10       Impact factor: 2.803

7.  Subcutaneous phaeohyphomycosis.

Authors:  Rosane Orofino Costa
Journal:  An Bras Dermatol       Date:  2010 Sep-Oct       Impact factor: 1.896

8.  Phaeohyphomycosis caused by Alternaria infectoria presenting as multiple vegetating lesions in a renal transplant patient.

Authors:  Daniela Cunha; Cristina Amaro; María Raquel Vieira; María da Luz Martins; Ana Paula Maduro; João Inácio; Ana Afonso; Gabriela Marques Pinto; Jorge Cardoso
Journal:  Rev Iberoam Micol       Date:  2011-07-07       Impact factor: 1.044

9.  Subcutaneous phaeohyphomycosis due to Curvularia lunata in a renal transplant patient.

Authors:  Elsa Vásquez-del-Mercado; Lorena Lammoglia; Roberto Arenas
Journal:  Rev Iberoam Micol       Date:  2012-11-12       Impact factor: 1.044

10.  Cutaneous infection caused by Alternaria in patients receiving tacrolimus.

Authors:  M Pereiro; Maria M Pereiro Ferreirós; G S De Hoog; J Toribio
Journal:  Med Mycol       Date:  2004-06       Impact factor: 4.076

  10 in total
  2 in total

1.  Subcutaneous Phaeohyphomycosis Due to Pyrenochaeta romeroi Mimicking a Synovial Cyst.

Authors:  Aurélien Dinh; Bruno Levy; Frédérique Bouchand; Benjamin Davido; Clara Duran; Marin Cristi; Adrien Felter; Jérôme Salomon; Nawel Ait Ammar
Journal:  Front Microbiol       Date:  2016-08-31       Impact factor: 5.640

Review 2.  Cutaneous Phaeohyphomycosis of the Right Hand Caused by Exophiala jeanselmei: A Case Report and Literature Review.

Authors:  Chongyang Wu; Ling Shu; Zhixing Chen; Qianrong Hu; Lijun Tao; Chao He
Journal:  Mycopathologia       Date:  2022-03-21       Impact factor: 3.785

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.